Sasipong, N. (2020). Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment. https://doi.org/10.11588/heidok.00027301
Chicago Style (17th ed.) CitationSasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. Heidelberg, 2020. https://doi.org/10.11588/heidok.00027301.
MLA (9th ed.) CitationSasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. 2020. https://doi.org/10.11588/heidok.00027301.
Warning: These citations may not always be 100% accurate.